Amgen reported $285M in Interest Expense on Debt for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
ALKERMES ALKS:US 1.87M 1000
Amgen AMGN:US $ 285M 33M
Biogen BIIB:US $ 64.7M 8.7M
Biomarin Pharmaceutical BMRN:US $ 3.8M 0.94M
Bristol Myers Squibb BMY:US $ 353M 2M
Eli Lilly And LLY:US $ 87.8M 1.4M
Genmab GEN:DC 3M 0
Gilead Sciences GILD:US $ 257M 10M
Intercept Pharmaceuticals ICPT:US $ 12.42M 0.17M
IONIS PHARMACEUT IONS:US $ 2.41M 9.09M
Johnson & Johnson JNJ:US $ 63M 24M
Moderna Inc MRNA:US 3M 506K
Neurocrine Biosciences NBIX:US $ 6.4M 1.4M
Novartis NOVN:VX 202M 1000K
Novartis NVS:US $ 202M 1M
Ptc Therapeutics PTCT:US $ 19.86M 4.63M
Puma Biotechnology PBYI:US $ 3.45M 0.12M
Regeneron Pharmaceuticals REGN:US $ 14.6M 0.2M
Sarepta Therapeutics SRPT:US $ 15.65M 3.08M
Teva Pharmaceutical TEVA:IT 239M 2M
Vertex Pharmaceuticals VRTX:US $ 15.68M 0.61M
YTE INCY:US $ 0.36M 0.07M